[1] Keech Jr JA. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plastic and reconstructive surgery. 1997;100(2):554-5.
[2] Loch-Wilkinson A, Beath KJ, Knight RJ, Wessels WL, Magnusson M, Papadopoulos T, et al. Breast implant–associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plastic and reconstructive surgery. 2017;140(4):645-54. https://doi.org/10.1097/PRS.0000000000003654.
[3] Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. US epidemiology of breast implant–associated anaplastic large cell lymphoma. Plastic and reconstructive surgery. 2017;139(5):1042-50. https://doi.org/10.1097/PRS.0000000000003282.
[4] Rastogi P, Riordan E, Moon D, Deva AK. Theories of etiopathogenesis of breast implant–associated anaplastic large cell lymphoma. Plastic and reconstructive surgery. 2019;143(3S):23S-9S. https://doi.org/10.1097/PRS.0000000000005566.
[5] Atiyeh B, Emsieh S. Breast implant illness (BII): real syndrome or a social media phenomenon? A narrative review of the literature. Aesthetic Plastic Surgery. 2022:43-57. https://doi.org/10.1007/s00266-021-02428-8.
[6] Tang YB, editor. Breast Reconstruction: Conceptual Evolution. BoD–Books on Demand; 2024.
[7] Lee KT, Kim S, Jeon BJ, Pyon JK, Mun GH, Ryu JM, et al. Association of the implant surface texture used in reconstruction with breast cancer recurrence. JAMA surgery. 2020;155(12):1132-40. https://doi.org/10.1001/jamasurg.2020.4124.
[8] Teughels W, Van Assche N, Sliepen I, Quirynen M. Effect of material characteristics and/or surface topography on biofilm development. Clinical oral implants research. 2006;17(S2):68-81. https://doi.org/10.1111/j.1600-0501.2006.01353.x.
[9] Hussain B, Grytten JI, Rongen G, Sanz M, Haugen HJ. Surface Topography Has Less Influence on Peri-Implantitis than Patient Factors: A Comparative Clinical Study of Two Dental Implant Systems. ACS Biomaterials Science & Engineering. 2024;10(7):4562-74. https://doi.org/10.1021/acsbiomaterials.3c01809.
[10] De Avila ED, Nagay BE, Pereira MM, Barão VA, Pavarina AC, Van Den Beucken JJ. Race for applicable antimicrobial dental implant surfaces to fight biofilm-related disease: advancing in laboratorial studies vs stagnation in clinical application. ACS Biomaterials Science & Engineering. 2022;8(8):3187-98. https://doi.org/10.1021/acsbiomaterials.2c00160.
[11] Danino MA, Nizard N, Paek LS, Govshievich A, Giot JP. Do bacteria and biofilm play a role in double-capsule formation around macrotextured implants?. Plastic and Reconstructive Surgery. 2017;140(5):878-83. https://doi.org/10.1097/PRS.0000000000003767.
[12] Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, et al. Breast implant–associated anaplastic large cell lymphoma: a systematic review. JAMA surgery. 2017;152(12):1161-8. https://doi.org/10.1001/jamasurg.2017.4026.
[13] Salvans S, Mayol X, Alonso S, Messeguer R, Pascual M, Mojal S, et al. Postoperative peritoneal infection enhances migration and invasion capacities of tumor cells in vitro: an insight into the association between anastomotic leak and recurrence after surgery for colorectal cancer. Annals of surgery. 2014;260(5):939-44. https://doi.org/10.1097/SLA.0000000000000958.
[14] Dorcaratto D, Mazzinari G, Fernandez M, Muñoz E, Garcés-Albir M, Ortega J, et al. Impact of postoperative complications on survival and recurrence after resection of colorectal liver metastases: systematic review and meta-analysis. Annals of surgery. 2019;270(6):1018-27. https://doi.org/10.1097/SLA.0000000000003254.
[15] Aoyama T, Murakawa M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, et al. Impact of postoperative complications on survival and recurrence in pancreatic cancer. Anticancer research. 2015;35(4):2401-9.
[16] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj. 2021;372. https://doi.org/10.1136/bmj.n71.
[17] Minozzi S, Cinquini M, Gianola S, Gonzalez-Lorenzo M, Banzi R. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application. Journal of clinical epidemiology. 2020;126:37-44. https://doi.org/10.1016/j.jclinepi.2020.06.015.
[18] Peterson J, Welch V, Losos M, Tugwell PJ. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2(1):1-2.
[19] Spoor J, Dieleman F, Bleiker EM, Koppert LB, Peeters MJ, Van Leeuwen FE, et al. Recurrence of breast cancer after reconstruction with macro-textured silicone breast implants: A retrospective cohort study. International Journal of Surgery. 2024:10-97. https://doi.org/10.1097/JS9.0000000000001878.
[20] Huang YY, Sacks B, Fahey MT, Farrell G, Poliness C, Webb A. Reviewing the risk of breast cancer recurrence following breast reconstruction. ANZ Journal of Surgery. 2023;93(7-8):1938-43. https://doi.org/10.1111/ans.18520.
[21] Ha JH, Cheun JH, Jung JJ, Kim HK, Lee HB, Shin HC, et al. Impact of implant surface type on breast cancer relapse after breast reconstruction: propensity score-matched study. British Journal of Surgery. 2023;110(10):1288-92. https://doi.org/10.1093/bjs/znad147.
[22] Wu ZY, Han HH, Han J, Son BH, Eom JS, Kim SB, et al. Breast cancer recurrence after smooth versus textured implant-based breast reconstruction: A matched cohort study. Plastic and Reconstructive Surgery. 2022;150:30S-7S. https://doi.org/10.1097/PRS.0000000000009491.
[23] Wu ZY, Han HH, Kim HJ, Lee JW, Chung IY, Kim J, et al. A propensity score-matched comparison of recurrence outcomes after immediate implant vs autologous flap reconstruction in patients receiving neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 2021;187:417-25. https://doi.org/10.1007/s10549-021-06114-w.
[24] Atlan M, Nuti G, Wang H, Decker S, Perry T. Breast implant surface texture impacts host tissue response. Journal of the mechanical behavior of biomedical materials. 2018;88:377-85. https://doi.org/10.1016/j.jmbbm.2018.08.035.
[25] Cole SW. Chronic inflammation and breast cancer recurrence. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2009;27(21):3418. https://doi.org/10.1200%2FJCO.2009.21.9782.
[26] Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant–associated lymphoma. Plastic and reconstructive surgery. 2015;135(2):319-29. https://doi.org/10.1097/PRS.0000000000000886.
[27] Meza Britez ME, Caballero LLano C, Chaux A. Periprosthetic breast capsules and immunophenotypes of inflammatory cells. European journal of plastic surgery. 2012;35:647-51. https://doi.org/10.1007/s00238-012-0728-9.
[28] Chan SA, Malik F, Wharton S, Klocke R. Systemic inflammatory disease resolution following cosmetic silicone breast implant removal. Case Reports. 2015;2015:bcr2014207418. https://doi.org/10.1136/bcr-2014-207418.
[29] Silva MM, Modolin M, Faintuch J, Yamaguchi CM, Zandona CB, Cintra W, et al. Systemic inflammatory reaction after silicone breast implant. Aesthetic plastic surgery. 2011;35:789-94. https://doi.org/10.1007/s00266-011-9688-x.
[30] Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. Journal of Clinical Oncology. 2009;27(21):3437-44. https://doi.org/10.1200/JCO.2008.18.9068.